1.32
price up icon0.76%   0.01
after-market Dopo l'orario di chiusura: 1.33 0.01 +0.76%
loading

Pliant Therapeutics Inc Azioni (PLRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
22.64%
45.59
58.94 62.01 60.64 52.39
Operating Income/Loss
22.64%
-45.59
-58.94 -62.01 -60.64 -52.39
Income/Loss From Continuing Operations Before Tax
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Net Income/Loss
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
61.39
61.22 60.73 60.38 60.18
Diluted Average Shares
0.27%
61.39
61.22 60.73 60.38 60.18
Basic Earnings Per Share
22.83%
-0.71
-0.92 -0.95 -0.92 -0.78
Diluted Earnings Per Share
22.83%
-0.71
-0.92 -0.95 -0.92 -0.78
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Capitalizzazione:     |  Volume (24 ore):